Alnylam Pharmaceuticals, Inc. Profile Avatar - Palmy Investing

Alnylam Pharmaceuticals, Inc.

Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic …

Biotechnology
US, Cambridge [HQ]
Value per Employee (VpE) · Surveys · Talents

Employees Analysis

Employee Surveys

Employees Asked: -

No survey available at the moment.

End of ALNY's Analysis
CIK: 1178670 CUSIP: 02043Q107 ISIN: US02043Q1076 LEI: - UEI: -
Secondary Listings